Morning everyone, great quarterly!
Most important takeaway for me is that the PMS Phase 2 trial results are still on track for a December 2023 readout.
Also, I’ll be listening to Acadia’s earnings call later this week and will share anything noteworthy. The actual Q2 Daybue sales should be announced and possibly updated guidance for Q3 sales.
Ann: Q2 2023 quarterly activity and cash flow report, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.26 |
Change
-0.280(2.23%) |
Mkt cap ! $1.525B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $6.952M | 570.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 231 | $12.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.32 | 1979 | 2 |
View Market Depth
| Last trade - 16.13pm 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |